Although bladder cancer ranks as the sixth most common cancer in the United States, with approximately 85,000 new cases diagnosed each year, it continues to receive limited awareness, advocacy, and ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...

A new treatment combination - Keytruda plus Padcev - is now approved for use before and after bladder‑removal surgery, ...

Of the approximately 82,000 people diagnosed with bladder cancer in the U.S. each year [1], many find their quality of life completely upended. Between demanding symptoms, side effects of treatment, ...

The increasingly more popular combination of Padcev and Keytruda has expanded its bladder cancer territory once again. | The ...

The Food and Drug Administration has approved a new treatment for patients with bladder cancer that does not respond well to standard therapy. The treatment, which will be sold under the brand name ...

A young boy from Kenya battled aggressive bladder rhabdomyosarcoma since early childhood. Doctors initially offered little ...

Signatera detects molecular residual disease in bladder cancer by identifying tumor DNA fragments in the bloodstream, even when not visible on scans. The IMvigor010 trial showed that Signatera-guided ...

Advanced bladder cancer is particularly difficult to treat, with few options available to doctors. Often, the first line of treatment is chemotherapy with or without radiation. Treatments for advanced ...

While potty training is probably a distant childhood memory, the panicked feeling of "I need to pee right now and I don't know if I can make it to the bathroom in time" is something many adults still ...

A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects. Results in mouse ...